9 studies were found.

1.		Completed	A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections
2.		Recruiting	Evaluation of Differing Taxanes/Taxane Combinations on the Outcomes of Patients with Operable Breast Cancer Condition: Breast Cancer
3.		Terminated	rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin Condition: Neoplasms, Gynecologic
4.		Completed	Rifabutin Therapy for the Prevention of Mycobacterium avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections
5.		Completed	Rifabutin Therapy for the Prevention of Mycobacterium avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections
6.		Completed	Rifabutin Therapy for the Prevention of Mycobacterium avium Complex (MAC) Bacteremia in HIV Positive Patients with CD4 Counts = or < 200: Treatment IND Study Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections
7.		Completed	A Study of Rifabutin, Used Alone or with Ethambutol in the Prevention of Mycobacterium avium Complex (MAC) Bacteremia in Patients with AIDS Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections
8.		Completed	A Study of Thymic Humoral Factor (THF gamma 2) in HIV-Infected Patients Condition: HIV Infections
9.		Completed	A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 mg) or Rifabutin (300 mg) or Placebo Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections